LivaNova (LIVN) Other Accumulated Expenses (2025 - 2026)
LivaNova (LIVN) reported Other Accumulated Expenses of $389.5 million for Q1 2026, up 8.07% on a YoY basis from $360.4 million in Q1 2025, and down 1.71% sequentially from $396.2 million in Q4 2025.
LivaNova (LIVN) Other Accumulated Expenses (2025 - 2026) Analysis & Trends
LivaNova (LIVN) has 2 years of Other Accumulated Expenses data on file, last reported at $389.5 million in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 8.07% year-over-year to $389.5 million; the trailing twelve-month figure through Mar 2026 stood at $389.5 million (up 8.07% YoY), and the FY2025 full-year result was $396.2 million, changed N/A from the prior year.
- Other Accumulated Expenses eased to $389.5 million in Q1 2026, from $396.2 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $396.2 million in Q4 2025 to a low of $360.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 389.49 Mn |
| Dec 31, 2025 | 396.24 Mn |
| Sep 30, 2025 | 394.59 Mn |
| Jun 30, 2025 | 392.27 Mn |
| Mar 31, 2025 | 360.39 Mn |